Cantuzumab ravtansine
MUC1 | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
(what is this?) (verify) |
Cantuzumab ravtansine (huC242-SPDB-DM4) is an
cytotoxic agent, ravtansine (DM4).[1] It uses a more hindered disulfide linkage than cantuzumab mertansine.[2]
See also
- Cantuzumab mertansine
- ImmunoGen Inc, developer of DM4 based drugs
References
- ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2). Archived from the original (PDF) on April 1, 2012.
- ISBN 978-1-4614-5456-4.